Overview

Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity

Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The aim of this project is to determine role for ET-1 in individuals with obesity.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Missouri-Columbia